Yes, all suspected adverse reactions to Mounjaro should be reported via the Yellow Card Scheme, particularly serious reactions, those causing hospitalisation, or any reactions not documented in the Summary of Product Characteristics
(August 1988)
what happened to weight management and metabolic care funding Weight management and metabolic care took the second highest funding position in H1 2026, and the pattern matched mental health almost exactly
There are also now two drugs on the market that are FDA-approved for weight loss -- Wegovy, a medication that contains the same main ingredient, semaglutide, as Ozempic, and Zepbound, a medication that contains the same main ingredient, tirzepatide, as Mounjaro
Unexplained Diarrhea with Weight Loss: While GLP-1s can cause gastrointestinal side effects, persistent, unexplained diarrhea combined with weight loss could, in rare instances, mask symptoms of hyperthyroidism, particularly if your levothyroxine dose is too high
In some cases, these symptoms can feel like pain, even though the heart is not involved
